OpenAI’s GPT-4 correctly diagnosed 52.7% of complex challenge cases, compared to 36% of medical journal readers, and outperformed 99.98% of simulated human readers, according to a study published by the New England Journal of Medicine.The…
Continue Reading
Leaders from Cleveland Clinic and Canon
What You Should Know:
– Cleveland Clinic and Canon Inc. have announced a strategic research partnership to develop innovative imaging and healthcare IT technologies aimed at improving diagnosis, care, and…
Continue Reading
In telehealth, diagnosing flu through patient-reported symptoms complicates accurate assessments. University of Georgia’s study explored clinical decision rules (CDRs) reliability in telemedicine, revealing discrepancies in patient and clinician symptom reports. The research, published in…
Continue Reading
Indonesia enables mobile EMR accessVerified users of SatuSehat can now access their medical records through the mobile health app, the Indonesian Ministry of Health announced.
This comes as the ministry finished integrating the SatuSehat platform…
While breast cancer garners widespread attention, mental health awareness often lingers in the shadows when compared to other medical conditions. The two diseases stand at opposite ends of the spectrum of diagnosis, treatment and…
Continue Reading
At RSNA23, Heuron showcases pioneering AI solutions for strokes, unveiling the Heuron StroCare Suite, including the ELVO component. The study demonstrated ELVO’s significant impact on diagnosing emergent large vessel occlusions using non-contrast CT scans….
Continue Reading
An innovative AI system, showcased at RSNA, accurately detects autism in 24 to 48-month-old children with a 98.5% success rate by analyzing specialized brain MRIs. Developed by a multi-disciplinary team led by Mohamed Khudri…
Continue Reading
What You Should Know:
Medical imaging technology company Medmo announced a $9 million funding round led by Lerer Hippeau,alongside existing investors Jerusalem Venture Partners (JVP), C2 Ventures and Stone IsraVentures.In addition, an array of notable angel investors participated, including Elliot Cohen,…
Continue Reading
“NeuroShield,” by InMed.AI, secures FDA clearance as a pioneering AI-driven tool quantifying brain volumes from MRI data. This groundbreaking platform offers ethnicity-specific reference ranges and aids neurodegenerative disease diagnosis and treatment planning. With impressive…
Continue Reading
Cleerly, a leading innovator in the field of cardiovascular disease diagnosis, today announced the launch of the TRANSFORM trial at the American Heart Association’s (AHA) 2023 Scientific Sessions. This groundbreaking trial aims to revolutionize…
Continue Reading
